B+
Bull case
20%
Probability
Target price
$110.00
+49.8% vs current
DXCM
DexComBNasdaq / Health Care Equipment & Services
Last Price
At close
2026-06-02
AI scenario view
RankAlpha Sentiment AIMost likely
B
Base case
55%
Probability
Target price
$80.00
+8.9% vs current
B-
Bear case
25%
Probability
Target price
$50.00
-31.9% vs current
AI sentiment snapshot
Latest data as of 2026-01-23
Recent news sentiment (30D)
-26.5
Negative
Company
-
Unavailable
Macro
-26.5
Negative
Pulse
-
Unavailable
Sentiment proxy
+55.8
Score
AI commentary
Sentiment is mixed: aggregators show medians in the low‑70s while individual analyst views span deeply bearish to strongly bullish, reflecting payer and competitive uncertainty [#SERP-1][#SERP-5]. Recent downgrades heighten near-term caution, though some sell-side conviction remains tied to product cycles and reimbursement outcomes [#SERP-6]. Overall tone is cautious-to-constructive ahead of guidance and payer news.
RankAlpha Sentiment AI - 2026-01-23
Open full AI memoEvidence flagged
No evidence quality warning is currently attached to this memo.
Impact
standard
Confidence
-
AI events
2026-03-31eventReimbursement / payer decisionsHigh impact
Material changes in Medicare or insurer CGM coverage would directly affect revenue trajectory; date uses a conservative window-end assumption.
2026-04-23catalystQuarterly results & guidanceHigh impact
Next quarterly report and any guidance update will likely reset the wide analyst target dispersion and trigger near-term repricing. [#SERP-1][#SERP-5]
2027-01-23catalystG7 adoption & international expansionHigh impact
Adoption of next‑generation CGM and traction outside the U.S. are primary multi-quarter drivers of revenue and valuation re-rating. [#SERP-2][#SERP-4]
Recommendation
N/A
No formal recommendation provided.
As of 2026-01-23 • Updated nightlySource: Internal modelMethodology